<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24074" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Laser Revision of Scars</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Xiao </surname>
            <given-names>Anny</given-names>
          </name>
          <aff>Western University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ettefagh</surname>
            <given-names>Leila</given-names>
          </name>
          <aff>Western University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anny Xiao declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leila Ettefagh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24074.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Scars result from the cutaneous wound healing process, leading to fibrosis and altered skin morphology. All wounds heal with some scar formation, and various scars can develop following surgery, trauma, and cutaneous inflammatory processes. Scars can have significant cosmetic, physical, and psychological impacts on patients, prompting many to seek treatment. Various treatment modalities have been utilized, with increasing evidence demonstrating the efficacy of lasers in improving several types of scars, including keloids, hypertrophic scars, atrophic scars, and acne scars. Laser technology advancements have enhanced laser devices' ability to improve the appearance, symptoms, texture, and pliability of all scar types. This activity describes the indications, contraindications, and types of lasers used to revise scars. It highlights the role of the interprofessional team in the care of patients undergoing laser scar revision.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate the different lasers used for scar revision.</p></list-item><list-item><p>Identify&#x000a0;the indications for laser scar revision.</p></list-item><list-item><p>Assess&#x000a0;the complications of laser scar revision.</p></list-item><list-item><p>Communicate&#x000a0;the importance of enhancing care coordination among the interprofessional team to improve care delivery for patients with scars and optimize patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24074">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24074.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Scars result from the cutaneous wound healing process, leading to fibrosis and altered skin morphology. All wounds heal with some scar formation, and various scars can develop following surgery, trauma, and cutaneous inflammatory processes.<xref ref-type="bibr" rid="article-24074.r1">[1]</xref> Scars can have significant cosmetic, physical, and psychological impacts on patients, prompting many to seek treatment. Various treatment modalities have been utilized, with increasing evidence demonstrating lasers' efficacy in improving different types of scars, including keloids, hypertrophic scars, atrophic scars, and acne scars.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref>Modern advancements in laser technology have enhanced the ability of laser devices to improve the appearance, symptoms, texture, and pliability of all scar types.</p>
      </sec>
      <sec id="article-24074.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Scar formation occurs due to cutaneous dermal injury. It is influenced by various etiologic factors:&#x000a0;genetic predisposition, depth, type, and location of the skin injury, the degree of tension, local infection or inflammation, and hormonal influences.<xref ref-type="bibr" rid="article-24074.r3">[3]</xref><xref ref-type="bibr" rid="article-24074.r4">[4]</xref>&#x000a0;Hypertrophic scars and keloids characteristically demonstrate abnormal fibroblast proliferation and excessive collagen production in response to a range of&#x000a0;skin injuries, often arising&#x000a0;with a familial tendency.<xref ref-type="bibr" rid="article-24074.r5">[5]</xref> Hypertrophic scars and keloids occur most commonly in those ages 10 to 30, with males and females equally affected.<xref ref-type="bibr" rid="article-24074.r4">[4]</xref> Keloids occur with a higher prevalence in African-American, Hispanic, and Asian populations, with an incidence of 4 to 16%.<xref ref-type="bibr" rid="article-24074.r6">[6]</xref>&#x000a0;Hypertrophic scars result from excessive collagen synthesis with&#x000a0;insufficient collagen lysis during the remodeling phase, forming&#x000a0;thick, hyalinized collagen bundles of fibroblasts and fibrocytes.<xref ref-type="bibr" rid="article-24074.r5">[5]</xref> In keloids, increased production of&#x000a0;transforming growth factor-beta results in a prolonged proliferative phase of wound healing and&#x000a0;significantly increased collagen synthesis by fibroblasts.<xref ref-type="bibr" rid="article-24074.r7">[7]</xref></p>
        <p>In contrast, atrophic scars are characterized by dermal depressions that&#x000a0;develop due to collagen destruction induced by cutaneous inflammation.<xref ref-type="bibr" rid="article-24074.r8">[8]</xref> This type of scar commonly occurs in&#x000a0;inflammatory diseases, such as acne vulgaris, varicella, and lupus, but may also result from surgery&#x000a0;or trauma.&#x000a0;Atrophic scars occur most commonly in patients with acne vulgaris, which affects up to 80% of those ages 11 to 30.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref> Atrophic scars are&#x000a0;3 times as common as keloids or hypertrophic scars<xref ref-type="bibr" rid="article-24074.r9">[9]</xref>.&#x000a0;Atrophic scars result from&#x000a0;diminished deposition of collagen factors due to an imbalance between the synthesis of scar matrix components and their degradation by proteases.<xref ref-type="bibr" rid="article-24074.r9">[9]</xref></p>
      </sec>
      <sec id="article-24074.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Indications for laser scar revision include atrophic, hypertrophic, and keloid scars in patients who desire an improvement in scar appearance and texture.&#x000a0;Hypertrophic scars are red or pink,&#x000a0;firm,&#x000a0;raised scars that remain within the border of the initial injury. They&#x000a0;form within the first month after the initial injury and may regress.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref> Keloids are pink&#x000a0;to purple, nodular, firmer scars extending beyond the original wound's margins. They may occur weeks to years after the initial injury and do not regress spontaneously.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref> Atrophic scars subclassify into ice pick, boxcar, and rolling scars. Ice pick scars&#x000a0;are narrow, deep, sharply marginated tracts that taper to a point at the base and extend vertically to the deep dermis or subcutaneous tissue.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref> Boxcar scars are round to oval depressions wider than ice-pick scars with sharply demarcated vertical edges. Rolling scars are wider than icepick or boxcar scars and characteristically show an undulating appearance of the skin due to abnormal fibrous tethering of the dermis to the subcutis.<xref ref-type="bibr" rid="article-24074.r9">[9]</xref></p>
      </sec>
      <sec id="article-24074.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications to laser therapy include the use of oral retinoids within the past year, pregnancy or breastfeeding, immunosuppression, connective tissue disorders, and the presence of any concomitant skin disease at the site of treatment. It is important to elicit information regarding herpes simplex virus history so prophylactic antiviral therapy can commence before the laser treatment.</p>
      </sec>
      <sec id="article-24074.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>Equipment required for the laser&#x000a0;revision&#x000a0;of scars include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Laser machine</p>
          </list-item>
          <list-item>
            <p>Digital camera</p>
          </list-item>
          <list-item>
            <p>Tray with a local anesthetic, post-laser emollient cream, anti-irritation gel, measurement tape</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24074.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Personnel required for the laser&#x000a0;revision of scars include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dermatologist</p>
          </list-item>
          <list-item>
            <p>Aesthetic medicine specialist</p>
          </list-item>
          <list-item>
            <p>Plastic surgeon</p>
          </list-item>
          <list-item>
            <p>Dermatology nurse</p>
          </list-item>
          <list-item>
            <p>Laser technician/ technologist</p>
          </list-item>
          <list-item>
            <p>Aesthetic technologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24074.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Scars should be thoroughly evaluated using a combination of clinical assessment and patient history to guide the appropriate treatment plan. They should be categorized as hypertrophic, keloidal, atrophic, or conventional. A history of the scar should be obtained to elucidate its age, previous scar treatments, and the preceding trauma, surgery, or inflammatory process. The patient's Fitzpatrick skin phototype should be a consideration. Pictures and measurements taken before each laser treatment can assist in monitoring progress and response to treatment. Scars should be clinically assessed at each visit, documenting pigmentation, pliability, and scar height. The scar should be treated with a topical anesthetic (eg, a cream) between 30 and 60 minutes before beginning treatment. The treatment area should be cleaned with an antiseptic solution before laser treatment.</p>
      </sec>
      <sec id="article-24074.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Laser scar revision utilizes&#x000a0;photothermal&#x000a0;energy to target intra- and extra-cellular structures within scar tissue to stimulate the eventual remodeling of dermal collagen and elastin. Various types of lasers have been used to treat scars since the 1980s, beginning with continuous-wave argon, CO2, and Nd:YAG 1064 lasers, followed by the application of&#x000a0;PDL and Er:YAG lasers for scar revision.<xref ref-type="bibr" rid="article-24074.r10">[10]</xref> Most recently, fractional photothermolysis with ablative and non-ablative fractionated lasers is an effective treatment for scars.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref></p>
        <p>For hypertrophic scars and keloids, the pulsed dye laser is the most common non-ablative laser (PDL: 585 to 595 nm).<xref ref-type="bibr" rid="article-24074.r2">[2]</xref> PDL effectively improves hypertrophic scars and keloids' vascularity, pliability, color, and height.<xref ref-type="bibr" rid="article-24074.r11">[11]</xref> Previous studies have reported a 57% to 83% improvement in hypertrophic scars' clinical appearance and texture after&#x000a0;1 to&#x000a0;2 PDL treatments.<xref ref-type="bibr" rid="article-24074.r12">[12]</xref>. The most commonly used non-ablative lasers for atrophic facial scars are Nd: YAG and 1450-nm diode laser. One study reported an improvement of 40 to 45%&#x000a0;with 1320-nm Nd: YAG or 1450-nm diode laser treatment after an average of&#x000a0;3 consecutive monthly treatment sessions, as assessed by patient satisfaction surveys, histologic evaluations, and skin texture measurements.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref> Non-ablative lasers have minimal downtime and produce gradual results, with the most significant improvement noted between 3 and 6 months following the final laser treatment.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref></p>
        <p>Non-ablative fractional lasers have significantly improved the pigmentation and thickness of surgical, atrophic, hypertrophic, and hypopigmented scars.<xref ref-type="bibr" rid="article-24074.r13">[13]</xref> A study by Tierney et al comparing 1550-nm non-ablative fractional lasers to 595-nm PDL for the treatment of surgical scars showed that non-ablative fractional lasers outperformed PDL, and 83% of patients preferred the half of the scar treated with a non-ablative fractional laser.<xref ref-type="bibr" rid="article-24074.r13">[13]</xref><xref ref-type="bibr" rid="article-24074.r14">[14]</xref>&#x000a0;Niwa et al examined non-ablative fractional lasers in treating hypertrophic scars and found 26% to 75% clinical improvement after&#x000a0;2 to&#x000a0;3 treatment sessions at 4-week intervals.<xref ref-type="bibr" rid="article-24074.r10">[10]</xref></p>
        <p>Ablative laser resurfacing, with CO2 or Er: YAG lasers, is effective for traumatic and surgical scars,&#x000a0;especially when resurfaced within 6 to 10 weeks after trauma or surgery or even immediately after surgery.<xref ref-type="bibr" rid="article-24074.r15">[15]</xref> CO2 and Er:YAG lasers are also effective for atrophic scars due to their ability to smooth scar texture and stimulate collagen production within facial atrophic scars,<xref ref-type="bibr" rid="article-24074.r16">[16]</xref> although patients must consider the&#x000a0;potential for significant downtime as re-epithelialization typically takes 4 to 7 days with Er: YAG and 7 to 10 days with the CO2 laser. While requiring more downtime, ablative lasers usually produce more clinical improvement.</p>
        <p>Previous head-to-head studies have suggested that CO2 laser produces superior results for acne scars, while Er:YAG is better tolerated with less downtime.<xref ref-type="bibr" rid="article-24074.r17">[17]</xref> Raised and shallow boxcar scars improve the most with laser resurfacing, while icepick scars are more challenging to treat and may necessitate secondary resurfacing.<xref ref-type="bibr" rid="article-24074.r15">[15]</xref> Non-ablative lasers are also useful for acne scars.</p>
        <p>More recently, fractional ablative laser resurfacing has emerged as a popular treatment modality for atrophic and surgical scars. In fractional ablative resurfacing, columns of thermal damage, called&#x000a0;microscopic thermal treatment zones, are separated by surrounding untreated skin. This results in rapid re-epithelialization and reduced downtime as only a fraction of the skin is altered.<xref ref-type="bibr" rid="article-24074.r18">[18]</xref> The microthermal treatment zones also allow fractional lasers&#x000a0;to penetrate the skin more deeply than fully ablative lasers.<xref ref-type="bibr" rid="article-24074.r19">[19]</xref> A double-blinded split-scar study&#x000a0;by Tidwell et al reported a significantly superior outcome with fractionated Er: YAG compared to&#x000a0;fully ablative Er: YAG for surgical scar revision, with 94% of patients preferring the side of the scar treated with fractional ablative resurfacing.<xref ref-type="bibr" rid="article-24074.r19">[19]</xref> Another study showed fractional CO2 laser to be effective in treating atrophic traumatic scars in 70% of patients treated with&#x000a0;6 monthly sessions of fractional CO2 laser treatment.<xref ref-type="bibr" rid="article-24074.r18">[18]</xref></p>
      </sec>
      <sec id="article-24074.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Adverse&#x000a0;effects of non-ablative laser options are generally mild and include transient erythema, which resolves within 24 hours. Blistering, crusting, scarring, and post-inflammatory hyperpigmentation are rare and occur most commonly in darker skin types.<xref ref-type="bibr" rid="article-24074.r2">[2]</xref> The most frequently encountered side effect of PDL treatment is post-treatment purpura, lasting for up to&#x000a0;1 week.<xref ref-type="bibr" rid="article-24074.r20">[20]</xref></p>
        <p>Non-ablative fractional resurfacing laser adverse&#x000a0;effects include mild to moderate pain during treatment and erythema and edema post-treatment lasting up to&#x000a0;2 to&#x000a0;4 days.<xref ref-type="bibr" rid="article-24074.r15">[15]</xref></p>
        <p>Side effects of ablative laser resurfacing include temporary burning discomfort, oozing, crusting, ulceration, erythema, edema,&#x000a0;acneiform eruptions, eczematous dermatitis, and infections.<xref ref-type="bibr" rid="article-24074.r15">[15]</xref> Long-term adverse effects include dyspigmentation and scarring.<xref ref-type="bibr" rid="article-24074.r18">[18]</xref> Erythema and edema typically worsen within&#x000a0;the first 24 to 48 hours after treatment, with erythema occasionally lasting up to&#x000a0;4 months post-treatment. One study reported an average duration of post-treatment erythema for&#x000a0;1 month.<xref ref-type="bibr" rid="article-24074.r21">[21]</xref> Transient postinflammatory hyperpigmentation occurs&#x000a0;2 to 4 weeks after treatment&#x000a0;and is more common in darker skin phototypes. In a study of Fitzpatrick skin types III to V, 45.5% developed&#x000a0;transient hyperpigmentation that resolved within&#x000a0;3 months in 90% of affected patients.<xref ref-type="bibr" rid="article-24074.r21">[21]</xref></p>
        <p>Fractional ablative laser resurfacing adverse effects are generally transient and less severe than fully ablative resurfacing.<xref ref-type="bibr" rid="article-24074.r20">[20]</xref><xref ref-type="bibr" rid="article-24074.r18">[18]</xref> Erythema, crusting, burning sensation, edema, and bruising were reported after fractional CO2 laser treatment.<xref ref-type="bibr" rid="article-24074.r18">[18]</xref> Persistent erythema and postinflammatory pigmentary changes are less common complications when compared to fully ablative skin&#x000a0;resurfacing.<xref ref-type="bibr" rid="article-24074.r18">[18]</xref></p>
      </sec>
      <sec id="article-24074.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Laser therapy for the treatment is an effective and safe treatment modality for multiple types of scars. Several studies have demonstrated high patient satisfaction rates with the cosmetic outcome of various&#x000a0;laser treatments. The emergence of fractional ablative laser devices has led to superior outcomes with decreased downtime compared to traditional fully ablative lasers, thereby increasing the appeal&#x000a0;of laser treatment for patients. In addition to making existing scars less noticeable, laser therapy can be used prophylactically to minimize&#x000a0;post-operative scarring.<xref ref-type="bibr" rid="article-24074.r11">[11]</xref> For symptomatic scars, lasers can reduce pruritus and pain. Lastly, laser treatment can increase the range of motion of debilitating scars that restrict movement.</p>
      </sec>
      <sec id="article-24074.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Scar revision using laser technology is an interprofessional process that involves the interplay of the primary caregiver, nurse practitioner, surgeon, and&#x000a0;a dermatologist with a special interest in aesthetics to achieve the best possible outcome for the patient. Primary healthcare professionals should refer patients with scars to a board-certified dermatologist or plastic surgeon with the necessary medical expertise and specialized knowledge in&#x000a0;treating scars with lasers. A medical consultation to review the patient's overall health, comorbidities, skin type, and scar characteristics&#x000a0;is essential to&#x000a0;treat a scar effectively. The outcomes of patients with scars are variable. In some cases, skin aesthetics can improve cosmesis. Lasers can cause several complications that can worsen the appearance of scars. Hence, laser therapy for scars requires professionals with experience with this device. The nurse has a crucial role in addressing the patient's fears and concerns before the day of surgery and assisting the clinician in educating the patient. A follow-up&#x000a0;of laser therapy in scar treatment requires an interprofessional approach with a liaison between the dermatologist and nursing staff, who have specialized training in dermatology, as the nurse may well be the initial point of contact and education for follow-up care. This team approach can ensure the best possible patient outcomes.</p>
      </sec>
      <sec id="article-24074.s13" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Ensure that the patient gives informed consent and is aware of the potential complications of the laser. In addition, the nurse should note the surgery site and record the findings in the chart.</p>
      </sec>
      <sec id="article-24074.s14" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>Considerations for interprofessional team monitoring include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vital signs</p>
          </list-item>
          <list-item>
            <p>Wound care</p>
          </list-item>
          <list-item>
            <p>Monitor for signs of infection</p>
          </list-item>
          <list-item>
            <p>Monitor for signs of skin irritation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24074.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24074">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24074/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24074">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24074.s16">
        <title>References</title>
        <ref id="article-24074.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>English</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Shenefelt</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Keloids and hypertrophic scars.</article-title>
            <source>Dermatol Surg</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>8</issue>
            <fpage>631</fpage>
            <page-range>631-8</page-range>
            <pub-id pub-id-type="pmid">10491047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khatri</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Mahoney</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>McCartney</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Laser scar revision: A review.</article-title>
            <source>J Cosmet Laser Ther</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>54</fpage>
            <page-range>54-62</page-range>
            <pub-id pub-id-type="pmid">21401378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alster</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Laser treatment of hypertrophic scars, keloids, and striae.</article-title>
            <source>Dermatol Clin</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>419</fpage>
            <page-range>419-29</page-range>
            <pub-id pub-id-type="pmid">9189679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niessen</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Spauwen</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Schalkwijk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>On the nature of hypertrophic scars and keloids: a review.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>104</volume>
            <issue>5</issue>
            <fpage>1435</fpage>
            <page-range>1435-58</page-range>
            <pub-id pub-id-type="pmid">10513931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfram</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tzankov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>P&#x000fc;lzl</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Piza-Katzer</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.</article-title>
            <source>Dermatol Surg</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>171</fpage>
            <page-range>171-81</page-range>
            <pub-id pub-id-type="pmid">19215252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robles</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Abnormal wound healing: keloids.</article-title>
            <source>Clin Dermatol</source>
            <year>2007</year>
            <season>Jan-Feb</season>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-32</page-range>
            <pub-id pub-id-type="pmid">17276198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foreman</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents.</article-title>
            <source>J Cell Sci</source>
            <year>1994</year>
            <month>May</month>
            <volume>107 ( Pt 5)</volume>
            <fpage>1137</fpage>
            <page-range>1137-57</page-range>
            <pub-id pub-id-type="pmid">7929624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanzi</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Alster</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Laser treatment of scars.</article-title>
            <source>Skin Therapy Lett</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-7</page-range>
            <pub-id pub-id-type="pmid">14716440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fabbrocini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Annunziata</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>D'Arco</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>De Vita</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lodi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mauriello</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Pastore</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Monfrecola</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Acne scars: pathogenesis, classification and treatment.</article-title>
            <source>Dermatol Res Pract</source>
            <year>2010</year>
            <volume>2010</volume>
            <fpage>893080</fpage>
            <pub-id pub-id-type="pmid">20981308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niwa</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Mello</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Torezan</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Os&#x000f3;rio</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Fractional photothermolysis for the treatment of hypertrophic scars: clinical experience of eight cases.</article-title>
            <source>Dermatol Surg</source>
            <year>2009</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>773</fpage>
            <page-range>773-7; discussion 777-8</page-range>
            <pub-id pub-id-type="pmid">19389105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nouri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rivas</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ballard</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vejjabhinanta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Elsaie</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Elgart</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the effectiveness of the pulsed dye laser 585 nm versus 595 nm in the treatment of new surgical scars.</article-title>
            <source>Lasers Med Sci</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>801</fpage>
            <page-range>801-10</page-range>
            <pub-id pub-id-type="pmid">19572180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keaney</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Tanzi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alster</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Comparison of 532 nm Potassium Titanyl Phosphate Laser and 595 nm Pulsed Dye Laser in the Treatment of Erythematous Surgical Scars: A Randomized, Controlled, Open-Label Study.</article-title>
            <source>Dermatol Surg</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <page-range>70-6</page-range>
            <pub-id pub-id-type="pmid">26673432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tierney</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mahmoud</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ozog</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kouba</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial.</article-title>
            <source>Dermatol Surg</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>8</issue>
            <fpage>1172</fpage>
            <page-range>1172-80</page-range>
            <pub-id pub-id-type="pmid">19250300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tierney</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Eisen</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Fractionated CO2 laser skin rejuvenation.</article-title>
            <source>Dermatol Ther</source>
            <year>2011</year>
            <season>Jan-Feb</season>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-53</page-range>
            <pub-id pub-id-type="pmid">21276157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexiades-Armenakas</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dover</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Arndt</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2008</year>
            <month>May</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>719</fpage>
            <page-range>719-37; quiz 738-40</page-range>
            <pub-id pub-id-type="pmid">18423256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>You</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Comparison of four different lasers for acne scars: Resurfacing and fractional lasers.</article-title>
            <source>J Plast Reconstr Aesthet Surg</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>e87</fpage>
            <page-range>e87-95</page-range>
            <pub-id pub-id-type="pmid">26880620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexiades</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Laser and light-based treatments of acne and acne scarring.</article-title>
            <source>Clin Dermatol</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>183</fpage>
            <page-range>183-189</page-range>
            <pub-id pub-id-type="pmid">28274357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sheikh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jabeen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rather</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mubashir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Latif</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zeerak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ashraf</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Younis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Saqib</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Treatment of post-burn and post-traumatic atrophic scars with fractional CO<sub>2</sub> laser: experience at a tertiary care centre.</article-title>
            <source>Lasers Med Sci</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>1039</fpage>
            <page-range>1039-1046</page-range>
            <pub-id pub-id-type="pmid">29473114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tidwell</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Kulp-Shorten</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maity</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McCall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial.</article-title>
            <source>Lasers Surg Med</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>837</fpage>
            <page-range>837-843</page-range>
            <pub-id pub-id-type="pmid">27426441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graber</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Tanzi</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Alster</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Side effects and complications of fractional laser photothermolysis: experience with 961 treatments.</article-title>
            <source>Dermatol Surg</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>301</fpage>
            <page-range>301-5; discussion 305-7</page-range>
            <pub-id pub-id-type="pmid">18190541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24074.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Ablative non-fractional lasers for atrophic facial acne scars: a new modality of erbium:YAG laser resurfacing in Asians.</article-title>
            <source>Lasers Med Sci</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>615</fpage>
            <page-range>615-9</page-range>
            <pub-id pub-id-type="pmid">23793338</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
